Increasingly, sickle cell anemia patients in the U.S. are moving away from blood transfusions and instead using a medicine called Hydroxyurea to control their disease and eliminate the symptoms. Cincinnati Children's Hospital Medical Center researchers are perfecting a technique that determines the correct dosage for each patient in one day.